Skip to main content
HR 4752 118th Congress House Health Health promotion and preventive care Medicare Neurological disorders

Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023

Introduced: March 19, 2024 Introduced by: Sánchez, Linda T. Democratic · California See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 21, 2023
Referred to the Subcommittee on Health.
Jul 19, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 19, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023 or the CHANGE Act of 2023

This bill specifies that Medicare annual wellness visits and initial preventive physical examinations must include the use of an approved tool from the National Institute of Aging to detect cognitive impairment, as well as associated documentation of the tool that was used and the results.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • EISAI INC.
    for EISAI INC. · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2026
 Cosponsors 35
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4752: Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4752/
MLA
"H.R. 4752: Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4752/.
Bluebook (legal)
H.R. 4752, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4752/.
Markdown link
[H.R. 4752: Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023](https://openamerica.io/bill/118-HR-4752/)
Report a problem